Serum Sodium as a Prognostic Factor in Decompensated Chronic Liver Disease by Senthilpriyan, K
SERUM SODIUM AS A PROGNOSTIC FACTOR
IN DECOMPENSATED
Submitted in partial 
M.D. DEGREE BRANCH I
THE TAMILNADU DR.M.G.R. MEDICAL UNIVERSITY
INSTITUTE OF INTERNAL
MADRAS MEDICAL COLLEGE
 CHRONIC LIVER 
DISEASE 
 
fulfillment of Requirements for
 
 
GENERAL MEDICINE 
OF 
CHENNAI 
 
 
 
 
 
 
 
 
 
 
 
 MEDICINE 
 
CHENNAI - 600 003 
APRIL - 2019 
 
 
 
 CERTIFICATE 
 
This is to certify that this dissertation entitled “SERUM SODIUM 
AS A PROGNOSTIC FACTOR IN DECOMPENSATED CHRONIC 
LIVER DISEASE” submitted by Dr.K.SENTHILPRIYAN appearing 
for M.D. Branch I – General Medicine Degree examination in  
APRIL - 2019 is a bonafide record of work done by him under my direct 
guidance and supervision in partial fulfilment of regulations of the 
TamilNadu Dr. M.G.R. Medical University, Chennai. I forward this to the 
TamilNaduDr.M.G.R. Medical University, Chennai, Tamil Nadu, India. 
 
 
Prof.Dr.P.VASANTHI., M.D.                       Prof.Dr.S.TITO,M.D., 
Professor of Medicine,                                 Director I/C and Professor, 
Institute of internal medicine,                       Institute of internal medicine, 
MMC & RGGGH,                                        MMC & RGGGH, 
Chennai- 600 003.                                        Chennai- 600 003. 
 
 
Prof.Dr.R.JAYANTHI M.D., FRCP.,(GLASG) 
The Dean, 
MMC & RGGGH, 
Chennai–3. 
 
 DECLARATION 
I solemnly declare that the dissertation titled “SERUM SODIUM 
AS A PROGNOSTIC FACTOR IN DECOMPENSATED CHRONIC 
LIVER DISEASE PATIENTS” is done by me at  
Madras Medical College & Rajiv Gandhi Govt. General Hospital, 
Chennai during AUGUST 2017 to JULY 2018 under the guidance and 
supervision of Prof.Dr.VASANTHI., M.D. The dissertation is submitted 
to The Tamilnadu Dr.M.G.R. Medical University towards the partial 
fulfilment of requirements for the award of M.D. Degree (Branch I) in 
General Medicine. 
 
 
 
Dr. K.SENTHILPRIYAN, 
Place:            M.D.General Medicine, 
Date:            Postgraduate student, 
Institute of Internal Medicine, 
Madras Medical College, 
Chennai. 
 
 
ACKNOWLEDGEMENT 
I would like to thank our beloved Dean, Madras Medical College, 
Prof.Dr.JAYANTHI, M.D., for his kind permission to use the hospital 
resources for this study. 
I would like to express my sincere gratitude to my beloved 
Professor and Director (I/C), Institute of Internal Medicine 
Prof.Dr.S.TITO, M.D., for his guidance and encouragement. 
With extreme gratitude, I express my indebtedness to my beloved 
Chief and teacher Prof.Dr.P.VASANTHI, M.D., for his motivation, 
advice and valuable criticism, which enabled me to complete this work. 
I am grateful to my former Chief and Director of Institute of 
Internal Medicine Prof.Dr.S.MAYILVAHANAN.M.D., for guiding and 
supporting me in this study. 
I am extremely thankful to Assistant Professors of Medicine 
Dr.P.BALAMANIKANDAN, M.D., and Dr.MOHAMMAD HASSAN 
MARICAR, M.D., for their co-operation and guidance. 
I thank all Professors, Assistant Professors, and Post-graduates of 
Institute of biochemistry and radiology for their valuable support in the 
analysis. 
I would always remember with extreme sense of thankfulness for 
the co-operation and criticism shown by my Postgraduate colleagues. 
I am immensely grateful to the generosity shown by the patients 
who participated in this study. 
Above all I thank my God Almighty for His immense blessings and 
guidance. 
 
 
 
 
 
 
 
  
ABBREVATIONS 
1 HBV HEPATITIS B VIRUS 
2 HCV HEPATITIS C VIRUS 
3 HDV HEPATITIS DVIRUS 
4 UGI UPPER GASTROINTESTINAL 
5 ECF EXTRACELLULAR FLUID 
6 DCLD DECOMPENSATED LIVER DISEASE 
7 PT PROTHROMBIN TIME 
8 INR INTERNATIONAL NORMALIZED RATIO 
9 SSRI SELECTIVE SEROTONIN REUPTAKE INHIBITORS 
10 TCA TRICYCLIC ANTIDEPRESSANTS 
11 MAO MONOAMINE OXIDASE 
12 TBW TOTAL BODY WATER 
13 ICF INTRACELLULAR FLUID 
14 mOsm MILLIOSMOLES 
15 PCT PROXIMAL CONVULUTED TUBULE 
16 AVP ARGININE VASOPRESSIN 
17 OVLT ORGANUM VASCULOSUM OF LAMINA TERMINALIS 
18 AQP AQUAPORIN 
19 EABV EFFECTIVE ARTERIAL BLOOD VOLUME 
20 CHF CONGESTIVE CARDIAC FAILURE 
21 Nacl SODIUM CHLORIDE 
22 GFR GLOMERULAR FILTRATION 
RATE 
23 CKD CHRONIC KIDNEY DISEASE 
24 CNS CENTRAL NERVOUS SYSTEM 
25 SIADH SYNDROME OF INAPPROPRIATE 
ANTIDIURETIC HORMONE 
26 Na SODIUM 
27 IL INTERLEUKIN 
28 NS NORMAL SALINE 
29 OLT ORTHOTOPIC LIVER 
TRANSPLANTATION 
30 CPS CHILD TURCOTTE PUGH SCORE 
31 MELD MODEL OF END STAGE LIVER 
DISEASE 
32 PHT PORTAL HYPERTENSION 
33 HRS HEPATORENAL SYNDROME 
34 SBP SPONTANEOUS BACTERIAL 
PERITONITIS 
35 mEq/L MILLIEQUALENTS PER LITRE 
36 SD STANDARD DEVIATION 
CONTENTS 
SERIAL 
NO TITLE PAGE NO 
1 INTRODUCTION 1 
2 AIMS AND OBJECTIVES 2 
3 REVIEW OF LITREATURE 3 
4 MATERIAL AND METHODS 40 
5 OBSERVATION AND RESULTS 42 
6 DISCUSSION 78 
7 CONCLUSION 82 
8 SUMMARY 83 
9 BIBLIOGRAPHY  
10 
ANNEXURES 
PROFORMA 
ETHICAL COMMITTEE APPROVAL 
PLAGIARISM SCREENSHOT 
PLAGIARISM CERTIFICATE 
INFORMATION SHEET 
CONSENT FORM 
MASTER CHART 
 
 
 
 
  
 
 
 
INTRODUCTION 
  
1 
 
INTRODUCTION 
Cirrhosis of liver is end of wide variety of chronic liver diseases like 
infections viral (HBV, HCV, HDV), toxic (alcohol, arsenic), metabolic, Biliary 
disorders, vascular lesion like Budd chiari syndrome. It’s defined as diffuse 
hepatic fibrosis associated with replacement of normal liver by nodules. The 
rate of progression of the disease varies depending on the etiological agent. 
Cirrhosis is leading cause of death and major cause of morbidity. Whatever the 
etiology 80 – 90 % of liver function has to be lost before hepatic failure ensues. 
Decompensated chronic liver disease is associated with ascites, Portal 
hypertension, UGI bleed,hepatorenal syndrome, coagulopathy, spontaneous 
bacterial peritonitis, hepatic encephalopathy. 
Serum sodium is major cation in the extracellular space and it is major 
contributor to ECF volume and oncotic pressure. Serum sodium decreased in 
patients with decompensated liver disease (DCLD)1,2,3-10.Hypernatremia is also 
associated with DCLD patients. Since hyponatremia is associated with various 
complications of DCLD,it can be used for assessing the prognosis of patients. 
Hyponatremia is defined as serum sodium less than 135meq/L 
Hypernatremia is said to be present when the serum sodium 
concentration is greater than 145meq/L 
This study is done to assess the importance of serum sodium in DCLD 
patients  and using it for predicting complications in them. 
  
 
 
AIMS AND OBJECTIVES 
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AIM OF THE STUDY 
 
Primary Objective  :  To study serum sodium levels in  
     decompensated liver disease patients and  
     complications associated with DCLD 
 
Secondary Objective  :  To relate the complications with serum  
    sodium levels and its correction with  
    reduction in complications 
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REVIEW OF LITERATURE 
In the body, there are Cations and anions. Cations are positively charged 
and include Sodium, Potassium, Magnesium and Calcium. While anions are 
negatively charged and include Bicarbonate, Chloride and Phosphate. They are 
involved in the metabolic activities and are required for normal functioning of 
the cell. 
Electrolytes concentrations in the body fluid, buffered within the cell. 
The concentration in each compartment varies. For comparison the 
concentration of sodium ions in extracellular fluid is 15 folds more than in the 
intracellular compartment. In contrary the concentration of potassium ions 
within the cells is 30 folds higher than the extracellular fluid.11 
INGREDIENTS OF BODY FLUIDS: 
Water forms the most abundant constituent in the body. In men it 
constitutes about 60% of body weight in females it constitutes around 50% of 
body weight. Water is distributed in two major compartments of the body. 
Total Body Water [TBW] is grouped into Intracellular Fluid [ICF] 
compartment and Extracellular Fluid [ECF] compartment. Of which ICF 
constitutes 55-75% of TBW while ECF amounts to 25-45% of TBW. ECF is 
further subdivided into interstitial fluid (extravascular) and Plasma 
(intravascular) in the ratio of 3:1as shown below. Lymphatic’s will circulate the 
fluid back into the intravascular compartment (plasma) from the extracellular 
space. 
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DISTRIBUTION OF TOTAL BODY WATER 70 KG 
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FIGURE 1: DISTRIBUTION OF TOTAL BODY WATER 
 
Osmolality is expressed as milliosmoles/kilogram(mOsm/Kg),defined as 
the concentration of all the solutes in a fluid, tonicity is defined as  the  
“effective” solute concentration that causes shift of fluid across fluid 
compartments. Sodium (Na+) forms most of ECF compartment solute 
concentration and anions [chloride(Cl-) and bicarbonate(HCO3-)] also 
contributes with it to solute concentration. But Potassium (K+) and some ions 
forms the constitute of ICF solutes. Urea will not cause any shift of water. The 
composition of major solutes in ECF and ICF is as follows 
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HOMEOSTASIS OF SODIUM AND WATER: 
The survival of each cell and its function in the body depends on the 
maintenance of ionic concentrations. The milieu is maintained by the tonicity 
of ECF, which is important determinant of intracellular fluid composition. The 
constancy of the ambient osmolarity is required for most steps in our 
physiology such as signaling pathways, neuronal depolarization, myocyte 
signaling etc., 
Extracellular tonicity is mostly determined by Serum Sodium 
concentration. Regulation of serum sodium is very important for normal 
functioning of the cell. So significant alterations in serum sodium is poorly 
tolerated and results in cellular dysfunction. Serum sodium is kept in a narrow 
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range even though there are variations in water consumption, intake of solutes 
and insensible water loss, since there is balance between water intake and water 
output. Serum sodium concentration is maintained by regulation of urinary 
tonicity. 
The various mechanisms in kidney maintains the Total Body Water 
content  such that it matches changes in serum sodium and potassium.Thirst 
control and excretion of water through urinary dilution and concentration 
regulates the water intake.Abnormalities in water balance results in 
Dysnatremias. 
Knowledge of both sides of water balance equation is required to signify 
the pathogenesis of dysnatremias in relation to water balance. In stools there is 
a loss of 1100 ml of water, there is loss through respiratory tract and from skin 
surface. For clearance of solutes kidneys excrete some water. A person on 
normal diet shall  excrete 400 mOsm of electrolytes and 500 mOsm of urea in 
which100 mOsm comes from diet and 400 mOsm from  ingestion of proteins. 
The maximum concentration of urine that can be attained in a normal 
individual is 1200 mOsm. Hence for the excretion of 900 mOsm of solutes a 
minimum amount of 750 mL water need to be excreted by the excretory 
system. 
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TABLE 1: WATER LOSS FROM THE BODY 
MODE OF WATER LOSS VOLUME 
  
STOOL 200ML 
  
SKIN THROUGH EVAPORATION 500ML 
  
RESPIRATORY TRACT 400ML 
  
EXCRETORY SYSTEM 750ML 
  
 
Water taken in different forms either as liquids, solid food and water is 
produced in cellular  metabolism makes up  the intake side of water balance. 
About 1200 mL of Water produced from metabolism, and through 
intake,which may equal to that of fixed non-urinary losses. So to match the 
urinary output of 1850 mL about 650 mL is to be consumed daily to maintain 
balance. 
As for as, person consumes this amount of water balance is maintained 
easily. Even when there is wide variation in the intake and non renal water 
losses kidney can maintain this balance. It is due to the concentrating capacity 
of the excretory system. 
If the amount of water ingested is more than required for the excretion 
of solutes, that  extra free water is excreted by way of dilution of urine. If there 
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is increased water loss in way of diarrhea, excessive sweating with normal 
intake of water, balance is maintained with increasing the concentration of 
urine and through stimulation of thirst. 
FUNCTION OF NEPHRON IN WATER BALANCE: 
Proximal Convoluted Tubule: (PCT) 
 Tight control of water balance is maintained by the Distal Nephron. For 
this to occur adequate amount of tubular fluid must reach the distal segment of 
the nephron. About 70% of the glomerular filtrate is reabsorbed from proximal 
convoluted tubule. The 30% of filtrate which is not reabsorbed which pass 
through the loop of Henle is required for the development of medullary 
interstitial tonicity gradient, this Interstitial gradient maintains the fluid 
balance. This decrease in delivery of fluid volume to distal segment of nephron 
will occur if there is reduction in glomerular filtration rate or if there is 
increased reabsorption in PCT. This will occur in conditions like volume 
depletion states like haemorrhage, and poor renal perfusion as in shock. 
The Loop of Henle: 
In the Henles loop mainly in the descending limb, water reabsorption 
occurs passively through the aquaporin-1 water channel, driven by the 
increased medullary hyper tonicity. As water moves out and the solute is added 
the osmolarity of tubular fluid reaches 1200 mOsm/L, this reaches the 
ascending segment. The thin ascending limb of Henle sodium is reabsorbed of 
passively, whereas in thick ascending limb, in which the segment is water 
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imperbeable,Na+/K+/2Cl-cotransporters pump will cause reabsorption of 
sodium, potassium and chloride ions. This will result in tubular fluid 
osmolarity to about 100 mOsm/L. 
In ascending limb of loop of Henle there is solute reabsorption without 
water reabsorption this results in hypo tonicity in tubular fluid. This influences 
the medullary interstitial gradient. This gradient is required for the AVP action. 
Medullary tonicity is maintained by GFR, reabsorption in proximal convoluted 
tubule and blood flow in the vasa recta. 
FIGURE 2: FORMATION OF URINE 
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Distal Tubule and Collecting Duct: 
 
The fluid reaching the collecting duct is hypotonic. The collecting duct 
is situated in the hypertonic medullary interstitium. It’s the place where fine 
tuning of water reabsorption occurs. Arginine Vasopressin (AVP) mainly 
determines the osmolarity of urine by maintaining the water excretion. 
Dysnatremias will occur due to defect in AVP action. 
ARGININE VASOPRESSIN: (AVP) 
Synthesis: Hypothalamus  
Stimulus:  Osmotic or non-osmotic stimuli. 
Osmoreceptors: Organum Vasculosum of the Lamina Terminalis 
(OVLT)    subfornical organ 
AVP secretion occurs in response to hyperosmolarity sensed by cell 
swelling, and it stimulates TR4 receptors. Conversely hypoosmolality will 
negatively feed back to inhibit AVP release. 
The serum sodium and serum osmolarity are interrelated and it is 
proven. When serum sodium is below 135 mEq/L AVP levels are undetectable 
in plasma. When the serum sodium levels reach 140 mEq/L, AVP levels reach 
5 pg/ml. AVP will function to maintain the serum osmolarity and serum 
sodium concentration within normal range. 
 
 FIGURE 3: 
 
 
 
 
 
 
 
 
 
 
 
 
AVP is also released in response to various other non osmotic 
Decreased intravascular volume or blood pressure (BP) also stimulates AVP 
release. Intravascular volume changes sensed by baroreceptors  found in atria 
and carotid artery. Any fall in plasma volume or fall in BP will send afferents 
through IX and X cranial nerves,this will cause AVP secretion
fall by 7% will trigger AVP secretion. This mechanism is important in water 
balance. 
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VASOPRESSIN SECRETION 
. Plasma volume 
stimulus. 
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The collecting tubule is water imperbeable. So fluid passing through it 
will not much change and will cause very dilute urine. But in the presence of 
AVP, water will be reabsorbed and tubular fluid becomes concentrated 
AVP acts on the V2 receptors on the basolateral membrane of collecting 
duct epithelium, Aquaporin 2(AQP2) receptors shifted to luminal membrane 
via cAMP pathway12.this will make the collecting tubule water permeable. This 
AVP’s action occurs within minutes.  
When plasma AVP secretion is elevated in a sustained manner, it results 
in increased expression of AQP2 and hence more AQP2 channels are available 
on the luminal side of the membrane to allow maximal water reabsorption in 
collecting tubule. This mechanism functions in volume overload states. As a 
result of AVP, urinary free water clearance is decreased; dilution of high serum 
sodium concentration and osmolarity of serum is maintained within normal 
range. There is feedback inhibition of AVP release if BP or Plasma volume is 
improved due to adequate water balance. 
  
 FIGURE 4
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 : AVP – MECHANISM AND RELEASE
 
 
 
 
 FIGURE : 5 FEEDBACK 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CONTROL OF THIRST
To maintain adequate water balance both AVP and Thirst mechanism is 
important. On a challenge with 
by stimulation of thirst in conjunction with AVP secretion. But latter will has 
more influence in water balance.
Thirst stimulation occurs at a higher osmolarity than AVP 
release4.Therefore, 2-3% increase in 
compared with 1% increase for AVP release
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OF VASOPRESSIN SECRETION
: 
hypertonic state water intake will be increased 
 
osmolarity is required to stimulate thirst, 
13
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FIGURE 6 : STIMULATION OF THIRST 
Thirst stimulation occurs at the osmotic set point, when the urine is 
maximally concentrated by the action of AVP. As a consequence, water intake 
is increased only when the kidneys ability to retain water is at maximum. Also 
thirst and in turn intake of water is influenced by other factors such as mouth 
dryness, hypovolemia, hypotension etc.,14,15. It is also suppressed by 
mechanoreceptors in oropharyngeal area when they sense fluid intake16 
In contrast to AVP’s minute to minute water regulation, thirst 
regulation that acts through gastrointestinal absorption of water, takes nearly 
one hour for the correction of osmolarity. Hence thirst regulation acts like a 
second line of defense in water balance. When there is overcorrection with 
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rapid fluid intake, transient suppression of AVP and thirst occurs which 
prevents drop in serum osmolarity. 
Maintenance of water balance occurs with the help of  thirst control and 
regulation of concentration of urine,despite wide variations in water intake and 
output. When situations affect this balance, dysnatremias may  occur. 
HYPONATREMIA 
 
Hyponatremia is the plasma concentration of sodium less than 
135mEq/L17. Hyponatremia is a common in patients admitted to hospitals most 
importantly in Intensive Care Unit. It total admission duration about 15-30% of 
patients has low serum sodium concentration at some point22. It results when 
kidney is unable to excrete either a water load or excess intake of water. 
Hyponatremia usually results, when there is an increase in secretion of   
AVP or increase in renal sensitivity to AVP, in addition to excess free water 
intake7. Thus, this disorder can occur when there is increase in TBW, or 
decrease in solutes or result of both. In most cases multiple mechanisms are 
involved. In assessing a patient with hyponatremia, the important  step is to 
ensure that the decrease in serum sodium is due to a hypoosmotic state and not 
due to pseudohyponatremia or translocational hyponatremia. 
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Pseudo-hyponatremia: 
It is also called normo-osmolal or isotonic hyponatremia. It is due to the 
increase in triglycerides or increase in the plasma proteins in diseases like 
Multiple Myeloma. In normal individuals, plasma water amounts to 93% of 
plasma volume and proteins, fats accounts to the remaining 7%. In conditions 
like hypertriglyceridemia or hyperproteinemia, the contribution of plasma 
water to plasma volume is decreased to 80%18,19. Plasma osmolality and plasma 
water sodium concentration remain unaffected. However, the measured sodium 
concentration is decreased because of the decrease in plasma water 
concentration in the sample. 
 
Translocational Hyponatremia: 
 
It is also called the hypertonic or redistributive hyponatremia. It is due to 
the presence of glucose or mannitol in the plasma, that are osmotically active 
solutes20. The presence of significant amounts of these unmeasured solutes in 
plasma affects the calculation of accurate plasma osmolality and hence requires 
direct measurement. 
After ruling out pseudohyponatremia and the presence of osmotically 
active solutes in ECF, determination  of ECF volume provides a useful way of 
classifying true hyponatremia (hypoosmolal hyponatremia) as it may  be 
associated with  decreased, normal or increased total body sodium. 
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1. Hyponatremia with depletion of ECF volume – Hypovolemic Hyponatremia 
2. Hyponatremia with excess ECF volume – Hypervolemic Hyponatremia 
3. Hyponatremia with normal ECF volume – Euvolemic  Hyponatremia 
 
FIGURE 7: CLASSIFICATION OF HYPONATREMIA BASED 
ON ECF VOLUME STATUS 
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HYPOVOLEMIC HYPONATREMIA: 
Causes: 
Extra Renal Causes:     Renal Causes: 
Diarrhea      Diuretic Excess 
Vomiting       Mineralocoticoid Excess 
Third Space loss       Salt Losing Nephritis 
Burns       Bicarbonaturia  
Pancreatitis      (Renal Tubular Acidosis),  
Trauma       Metabolic Alkalosis  
Muscle       Ketonuria  
      Osmotic Diuresis 
It occurs when the decrease in total body sodium is out of proportion to 
decrease in total body water. AVP secretion is stimulated by the decrease in 
intravascular volume and fall in blood pressure. This non osmotic stimulus 
overrides the suppression of the AVP release by osmoreceptors that detect 
hypoosmolality, as described in the “Law of the Circulating Volume”. It states 
that the preservation of blood volume and the maintenance of blood pressure 
take precedence over maintenance of the tonicity. 
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AVP acts on V1A receptors in the blood vessels to maintain blood 
pressure and V2 receptors in kidney to increase water reabsorption. V2 receptor 
activation can result in hyponatremia if there is increased free water intake. 
HYPERVOLEMIC HYPONATREMIA: 
 
It is a condition in which both the total body sodium and water are 
increased, but the retention of water is more and out of proportion to the 
retention of sodium. This is mostly seen with disorders with volume overload 
states such as cirrhosis of liver, heart failure and the severity of the 
hyponatremia is thought to be used as a marker of severity as well as 
prognostic indicator of the underlying disease. The mechanism by which 
hyponatremia occurs in these disorders can be due to the hormonal and intra-
renal changes are related to low Effective Arterial Blood Volume (EABV)21. 
Hyponatremia is associated in patients with advanced Congestive Heart 
Failure(CHF)22,23. It is an indicator of poor prognosis24. Cardiopulmonary 
congestion and reduced left sided output will result in under filling of arteries. 
This is interpreted by the mechanoreceptors present in left ventricle, aortic 
arch, carotid sinus and afferent arterioles in kidney25. Activation of these 
receptors results in increased sympathetic outflow, activation of the renin-
angiotensin-aldosterone system which causes a decrease in GFR and enhanced 
reabsorption in proximal tubules. This results in decreased delivery of water to 
distal nephron and hence, inability to achieve adequate medullary interstitial 
tonicity gradient, thus resulting reduced free water clearance. Activation of the 
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mechanoreceptors also causes non osmotic release of AVP and stimulation of 
thirst. Both AVP release and increased free water intake due to thirst combine 
to produce hyponatremia. Also, expression of AQP2 has been increased, 
causing greater reabsorption of water in the presence of AVP in animal studies 
with advanced CHF26. 
Cirrhosis is another condition in which hypervolemic hyponatremia is 
seen. Vasodilatation in the splanchnic and the peripheral circulation leads to 
low EABV. This low EABV, like in the CHF leads to hyponatremia. 
Hypervolemic hyponatremia has been reported in the Nephrotic 
syndrome patients also, but their presence is inconsistent and unrelated to the 
severity of disease. Hypervolemic hyponatremia has also been reported in 
patients with renal failure27,28. Recent studies have showed, prevalence of 
hyponatremia of about 15% in chronic kidney disease (CKD) patients 
EUVOLEMIC HYPONATREMIA: 
 
This occurs when there is an increase in total body water without 
change in the level of total body sodium concentration. This type of 
hyponatremia is seen mostly in hospitalized patients29 and it is due to various 
causes that has a common mechanism- unregulated AVP release and 
unprovoked by either the osmotic or non-osmotic factors. Syndrome of 
Inappropriate Anti-Diuretic Hormone (SIADH) is the well recognized cause 
of euvolemic hyponatremia. It is the most common cause of hyponatremia30.  
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Causes: 
URINE Na >20 mEq/L 
SIADH 
Hypothyroidism 
Glucocorticoid deficiency 
Drugs  
 
URINE Na >20 mEq/L 
Primary polydipsia 
Exercise induced 
Beer potomania 
 
  
24 
 
HYPERNATREMIA 
Hypernatremia is defined as the serum concentration of sodium more 
than145 mEq/L, it occurs in about 1% of hospitalized patients31 and 7% of 
patients who are admitted in the intensive care units32. Even though it is 
uncommon to be a primary cause of death, as much as 40% mortality has been 
reported in patients with Hypernatremia. 
PATHOPHYSIOLOGY: 
Hypernatremia occurs due to disequilibrium of water balance in which, 
there is an excess of sodium in comparison with water in ECF. Mostly it’s due 
to water deficit and sometimes due to sodium overload. Water deficit may be 
due to inadequate intake or excessive water loss. Patients with appropriate 
thirst control and access to fluid intake will maintain balance. 
As a consequence of increased sodium in the ECF, the osmotic load 
increases and this is compensated by loss of the water from inside the cells. 
This results in shrinkage of the cells due to dehydration. The cells will respond 
to the shrinkage of the cell by transporting solutes across the cell membrane, 
thus alter the resting potentials of electrically active cell membrane. For 
avoidance of structural damage and to restore the cell volume, organic solutes 
are produced intracellularly. 
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These effects of cellular dehydration and the shrinkage of cell with 
alteration in membrane potentials are primarily manifested in the CNS leading 
to ineffective functioning. When shrinkage of the neurons is severe, it leads to 
stretching and may cause rupture of the bridging veins. 
 
Infants, elderly and the debilitated patients are dependent on the 
caregiver for providing water. They are at risk of hypernatremia. Essential or 
adipsic hypernatremia occurs as a result of congenital or acquired defect of the 
osmoreceptors present in the hypothalamus. This results in   dysregulation of 
vasopressin release and the thirst response leading to hypernatremia with 
hypovolemia. 
 
Renal water loss occurs as a result of loss of ability of the distal tubule 
to concentrate urine. This occurs from failure of vasopressin action which leads 
to defective reabsorption of water from distal tubules. It can be due to, 
 
1. Inadequate Pituitary Secretion of AVP - Central Diabetes Insipidus 
2. Resistance at the level of receptors for AVP – Nephrogenic Diabetes 
Insipidus 
 
These patients excrete more amount of dilute urine and do not develop 
hypernatremia as long as they can maintain their water intake to compensate 
for their losses. Another common cause for excess loss of water through renal 
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system is the osmotic diuresis. This result secondary to hyperglycemia, 
mannitol, excess urea and post-obstructive diuresis. 
Extra renal fluid loss can occur in the background of fever, severe burns, 
exposure to heat, vigorous exercise and mechanical ventilation. Diarrhea is the 
leading cause of hypernatremia due to the gastrointestinal pathology. Osmotic 
diarrhea is more likely to cause hypernatremia than secretory diarrhea. Osmotic 
diarrhea and viral gastroenteritis produce stools with sodium and potassium of  
< 100 mM,causing  hypovolemia and hypernatremia. Secretory diarrhea will 
cause isotonic stools and hypovolemic hyponatremia. 
Sodium excess due to use of intravenous fluids (0.9% NaCl) to correct 
insensible water loss can cause hypernatremia. It can also be seen following 
sodium bicarbonate administration for the correction of metabolic acidosis, use 
of high sodium dialysate and intrauterine instillation of the hypertonic saline 
for pregnancy termination. 
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FIGURE 8: EVALUATION OF HYPERNATREMIA 
 
 
 
DECOMPENSATED CHRONIC LIVER DISEASE: 
 Chronic liver disease indicates the disease of the liver that results in 
progressive destruction and regeneration of its parenchyma leading ultimately 
on to fibrosis and cirrhosis. Chronic liver disease is said to be present when the 
disease process lasts for more than six months. It is important for the clinicians 
to differentiate chronic liver disease patients into those with compensated liver 
function and those with decompensated liver function. 
Patients with chronic liver disease can present to us with 
decompensation in any one of the following conditions. 
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i. Ascites 
ii. Variceal Bleed 
iii. Hepatic Encephalopathy 
iv. Hepato Renal Syndrome 
v. Coagulopathy 
vi. Hepatopulmonary Syndrome 
vii. Hepatocellular carcinoma 
 
PATHOPHYSIOLOGY OF CHRONIC LIVER DISEASE: 
Hepatocellular injury due to various pathologies is followed by 
degeneration or else necrosis of the hepatocyte. Necrosis in turn leads to 
kupffer cell activation and macrophage infiltration. T lymphocytes are also 
recruited. They are activated in response to secretion of  IL-1. Fibroblasts are 
also attracted to the site and they are transformed into myofibroblasts, which 
are in turn responsible for the increased synthesis of collagen and extra cellular 
matrix proteins. 
Bridging fibrous septa are developed, which link portal tracts with one 
another and also with terminal hepatic veins. Fibrosis is the hallmark feature of 
progressive damage of the liver. Nodules are formed due to alternate 
hepatocyte scarring and regeneration. The resultant diffuse fibrosis causes 
disruption of the entire architecture of the liver. The histopathological 
consequence of chronic injury to the hepatocytes, inflammation with formation 
of fibrosis and nodularity surrounded by collagen bands is termed as cirrhosis. 
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This leads to reduced liver mass and defective hepatocellular function. 
The altered architecture provides mechanical resistance to normal blood flow 
through the liver. 
FIGURE 9: Histopathology of cirrhosis of liver 
 
 
 
 
 
 
 
 
 
It shows altered architecture and nodularity 
 
CAUSES OF CHRONIC LIVER DISEASE: 
 
Whatever the inciting cause, the clinical presentation and complications 
of cirrhosis are more or less similar. Nevertheless, it is noteworthy to classify 
the patients on the basis of their etiology. Following is list of various causes of 
chronic liver disease. 
 
 
30 
 
CAUSES OF CIRRHOSIS 
i. Alcoholism 
ii. Chronic viral hepatitis 
1. Hepatitis B 
2. Hepatitis C 
iii. Biliary cirrhosis 
1. Primary Biliary cirrhosis 
2. Primary sclerosing cholangitis 
3. Autoimmune cholangiopathy 
iv. Cardiac cirrhosis 
v. Autoimmune hepatitis 
vi. Non alcoholic steatohepatitis 
vii. Inherited metabolic liver disease 
a. Hemochromatosis 
b. Wilson’s disease 
c. Alpha 1 antitrypsin deficiency 
d. Cystic fibrosis 
viii. Cryptogenic cirrhosis 
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FIGURE 10: COMPLICATIONS OF CIRRHOSIS 
Relation of serum sodium in DCLD 
Hyponatremia is a most common complication in patients with 
decompensated liver disease. It results due to the impaired free water clearance 
by renal tubules of the kidneys that lead to disproportionate retention of water 
when compared to that of serum sodium. This eventually results in reduction in 
serum sodium and hypoosmolality. Although hyponatremia in decompensated 
liver disease was known 50 years ago, interest in this area increased when 
studies which were done in 1980s shows that hyponatremia is important 
prognostic indicator. 
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Recent studies also showed that the presence of hyponatremia is 
associated not only with poor outcome in patients who has not undergone 
transplants but also in transplant recipients’ also. 
HYPONATREMIA: 
Although hyponatremia in the general population is defined as the 
concentration of serum sodium less than 135 mEq/L, in patients with chronic 
liver disease and ascites, it is defined as serum sodium less than 130 mEq/L. 
Even though, patients with serum sodium levels between 130 and 135, have 
pathogenic and clinical features almost similar to those with patients who have 
levels below 130 mEq/L. 21.6% of patients with DCLD have serum sodium 
less than 130 and 49.4% have serum sodium levels less than 135 mEq/L. 
TYPES OF HYPONATREMIA: 
 
Patient with decompensated liver disease present either with 
hypervolemic hyponatremia or hypovolemia hyponatremia. 
Hypervolemic Or Dilutional Hyponatremia: 
 
This is the most common type of hyponatremia. It seen in patients with 
increased extracellular fluid and edema. Hyponatremia results due to impaired 
ability of the kidneys to excrete free water that results in inappropriate increase 
in water retention when compared to sodium. Renal impairment is 
characteristic but not always present with this type. 
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Hypovolemic Hyponatremia: 
 
It is less common when compared to above type and occurs due to loss 
of fluid, mainly from kidney due to increased diuresis as a result of diuretic 
usage or from gastrointestinal tract loss. It is associated with reduction in 
plasma volume, absence of ascites or pedal edema, signs of dehydration will be 
there and pre-renal failure. These patients will show an improvement of serum 
sodium levels after administration of normal saline (NS) or by increasing 
quantity of sodium intake in the diet. 
Both types can be differentiated on the basis of the volume status of the 
patient. In hypervolemic hyponatremia, the effective arterial blood volume is 
reduced; eventhough there is increase in absolute plasma volume due to the 
marked dilatation of the arterial circulation. 
PATHOGENESIS OF HYPONATREMIA IN DCLD: 
 
Patients who has decompensated liver disease and ascites, there is 
impaired ability of kidneys to excrete solute free water2,33. In some patients, the 
impairment will be moderate and can be detected by measuring urine volume 
following a water load. These patients can excrete water normally and maintain 
sodium concentration within normal limits as long as their intake of water is 
maintained within normal range. But when the intake of water is increased, 
these patients may develop hyponatremia and hypoosmolality. Figure 11 shows 
the mechanisms involved in renal water handling in the patients causing 
hyponatremia. 
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FIGURE 11: WATER HANDLING IN CIRRHOSIS 
 
 
 
 
 
 
 
 
 
 
The important determinant of hyponatremia is increased release of AVP 
as a response to non-osmotic stimulation following changes in circulation in 
patients with decompensated liver disease. 
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WATER RETENTION IN DECOMPENSATED LIVER DISEASE: 
Water loading test is performed by giving 20 ml/kg body weight of 
water to be taken over 45 minutes. In normal individuals, water loading will 
result in production of maximally diluted urine and increase in urine output. In 
patients with compensated non-ascitic chronic liver disease, the response to 
water load is normal. However, in decompensated chronic liver disease 
patients, solute free water clearance is deranged after administering water load 
and the kidneys are not able to generate hypotonic urine. 
There are various studies which have provided evidence that AVP is a 
major factor responsible for water retention in cirrhosis34. In a study of patients 
with ascites and cirrhosis, patients losing more than 80% of water load over 5 
hours were classified as excretors and those losing less than 80% were 
classified as nonexcretors. Serum AVP were measured before and after water 
loading. It was found that although baseline AVP levels of nonexcretors were 
higher than that of excretors, the difference was not that significant. However, 
the nonexcretors were unable to suppress the AVP levels as that of the 
excretors after water loading and the difference was significant. The study also 
found a significant correlation between the plasma AVP level and the 
percentage of water load that was excreted. 
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MECHANISM OF RETENTION OF WATER AND DILUTIONAL 
HYPONATREMIA: 
Decreased Metabolism of AVP: 
AVP is metabolized in the liver and kidney. In patients with deranged 
liver function due to chronic liver disease, metabolic clearance rate of AVP is 
reduced and its level increases. This alone does not explain the whole process 
of dilutional hyponatremia, as the increase in AVP levels should exert a 
negative feedback on their own release if osmotic factor is alone responsible 
for the regulation of AVP. The mechanism of dilutional hyponatremia is shown 
in figure. 
 
FIGURE 12:  MECHANISM OF HYPONATREMIA IN CIRRHOSIS 
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PROGNOSTIC SCORE: 
The prognostic scores in decompensated liver disease can be used for 
various reasons. They provide help in identifying patients at risk for developing 
complications, to predict the risks involved in various procedures such as 
porto-systemic shunts, to categorize the patients waiting for Orthotopic Liver 
Transplantation (OLT). 
CHILD- TURCOTTE PUGH SCORE: (CPS) 
 
The score was developed by Child and Turcotte in 1964. It includes 
serum bilirubin, serum albumin, ascites, clinically apparent encephalopathy and 
malnutrition35. Each variable was given points according to the severity or 
based on cut-off ranges. Further patients were classified in to three groups of 
worsening severity (A,B,C). A modification of this score made by Child-Pugh 
later to predict outcome from surgical procedures used to reduce PH and to 
treat esophageal varices.36 
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FIGURE 13: MODIFIED CHILD PUGH SCORE 
 
MELD SCORE: 
Its calculated based on the variables serum bilirubin, serum creatine and 
INR values. They are used to predict the mortality rate depending on the score. 
It’s used to prioritize patients for liver transplantation and trans jugular 
intrahepatic port systemic shunts. 
MELD SCORE = 3.78[loge  serum bilirubin (mg/dl)] + 11.2[loge  INR] 
+ 9.57[logeserum creatinine (mg/dl)] + 6.43 
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SERUM SODIUM AS A PROGNOSTIC MARKER: 
The prognostic value of serum sodium has been studied in patients with 
decompensated liver disease. A large study done on the patients admitted for 
cirrhosis, has shown that the prevalence of hyponatremia was found to be 
29.8%.37 Low serum sodium levels were found to be associated with poor 
prognosis and in-hospital mortality early. When compared with CPS,Low 
serum sodium levels were not found to be an independent predictor of 
mortality.38 Biggins et al showed that the MELD score able  to predict three 
month waiting list mortality improved when serum sodium is also  added to 
it.39 The mortality risk for patients with decompensated liver disease associated 
with hyponatremia was found to be higher  irrespective of the disease 
severity.40 
 
 
 
  
  
 
 
MATERIALS AND METHODS 
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MATERIALS AND METHODS 
 
Study Centre : Institute of Internal Medicine, Madras Medical  
  College and Rajiv Gandhi Government General  
  Hospital, Chennai 
 
Duration of the Study:  August 2017 to July 2018 
 
Sample Size     :  145 patients 
 
Methodology       :  Sample size of the study was calculated using the  
   formula 4*pq/d, p=prevalence of the disease,       
     q=1-p,d=error range.145 patients were studied. 
 Patients who were admitted in our medical ward and willing for the 
study were included, subjected to clinical history and examination. Blood 
samples were collected for liver function tests, serum electrolytes and 
coagulation profile (PT, INR). Ultrasonogram of abdomen was done and 
assesed for the liver echoes to confirm the nature of the disease. Portal vein 
Doppler study and Ascitic fluid analysis were done.  
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Study Design :  Prospective observational study 
Inclusion Criteria  : Decompensated liver disease patients were  
    diagnosed by clinical history, examination,  
    biochemical investigations and imaging  
    studies like USG Abdomen 
Exclusion criteria  : Patients with CCF, CKD, on drugs   such as  
    SSRI’s, TCA’s, MAO inhibitors, cytotoxic  
    drugs 
Statistical analysis plan : Data analysed using statistical package - SPSS  
   software 
Consent :  Written consent were obtained from the patient and  
   attender.  
Ethical Committee  
Approval :  Institutional ethical committee of Madras  
   Medical College approved the study. 
  
  
 
 
 
OBSERVATION AND RESULTS 
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OBSERVATION AND RESULTS 
AGE DISTRIBUTION 
In this study, 145 patients are included based on eligibility criteria, 
following table depicts the age distribution. Most of them were above 40 years. 
The mean age is 51.75 years 
TABLE 2 : AGE DISTRIBUTION 
 
 
 
 
 
 
 
  
AGE GROUP(YRS) NO OF PATIENTS 
31 – 40 16 
41 – 50 50 
51 – 60 35 
61 – 70 35 
>70 9 
TOTAL 145 
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FIGURE 14: AGE DISTRIBUTION 
 
 
 
  
 TABLE 3
Of the 145 patients 142 were male and 3 were female.
 
MALE 
FEMALE 
 
FIGURE: 15 SEX DISTRIBUTION
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SEX DISTRIBUTION 
 : SEX DISTRIBUTION 
 
NO OF PATIENTS PERCENTAGE
142 98%
3 2% 
 
 
Male
142
98%
Female
2%
 
 
 
3
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TABLE 4 : CAUSE OF DCLD 
Regarding the etiology of DCLD 142 were related to alcoholism and 3 
were due to Hepatitis B 
 
 
FIGURE 16 ETIOLOGY OF DCLD 
  
3, 2%
142, 98%
HbsAg Positive
HbsAg Negative
ETIOLOGY NO OF PATIENTS PERCENTAGE 
ALCOHOLISM 142 98% 
HBV POSITIVE 3 2% 
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COMPLICATIONS ASSOCIATED WITH DCLD 
TABLE 5 : ASCITES 
About 122 patients were associated with massive ascites and about 23 
were not associated with ascites. 
ASCITES NO OF PATIENTS PERCENTAGE 
MILD 0 0 
MASSIVE 122 84.1% 
NIL 23 15.9% 
 
 
FIGURE 17: SHOWING DEGREE OF ASCITES 
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TABLE: 5 PORTAL HYPERTENSION 
Of the 145 patients 89 patients has PHT and constitute about 61%.about 
39%patient has no PHT. 
PORTAL HT NO OF PATIENTS PERCENTAGE 
PRESENT 89 61.4% 
ABSENT 56 38.6% 
TOTAL 145 100 
 
FIGURE: 18 DISTRIBUTION OF PORTAL HT 
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PORTAL HT 
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 TABLE
Of the 145 patients,30 patients has upper GI bleed which constitutes 
20.7%.and those without UGI bleed was 115 patients(79.3%)
UGI BLEED 
PRESENT 
ABSENT 
TOTAL 
 
FIGURE: 19 DISTRIBUTION OF UGI BLEED
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 : 6 DISTRIBUTION OF UGI BLEED 
 
NO OF PATIENTS PERCENTAGE
30 20.7%
115 79.3%
145 100
 
 
115
UGI BLEED ABSENT
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TABLE: 7 DISTRIBUTION OF COAGULOPATHY 
Of the 145 patients 22 patients has coagulopathy, it is about 15.3%. 
COAGULOPATHY NO OF PATIENTS PERCENTAGE 
PRESENT 22 15.3% 
ABSENT 123 85.7% 
TOTAL 145 100 
 
 
FIGURE:20 DISTRIBUTION OF COAGULOPATHY 
 
 
 
  
22, 15%
122, 85%
Coagulopathy Yes
Coagulopathy No
50 
 
TABLE: 8 DISTRIBUTION OF HEPETORENAL SYNDROME 
About 16 patients of 145 has hepatorenal syndrome. It is about 
11%.remaining 89% has no HRS 
HEPATORENAL 
SYNDROME 
NO OF PATIENTS PERCENTAGE 
PRESENT 16 11% 
ABSENT 129 89% 
TOTAL 145 100 
 
FIGURE: 21 DISTRIBUTION OF HEPETORENAL SYNDROME 
 
  
16, 11%
129, 89%
HRS Yes
HRS No
 TABLE: 9 DISTRIBUTION OF SPONTANEOUS 
Of the 145 patients 14 developed spontaneous bacterial peritonitis. It 
was about 10%  
SPONTANEOUS 
BACTERIAL 
PERITONITIS 
PRESENT 
ABSENT 
TOTAL 
 
FIGURE: 22 DISTRIBUTION OF SPONTANEOUS BACTERIAL 
51 
BACTERIAL PERITONITIS 
NO OF PATIENTS PERCENTAGE
14 10%
131 90%
145 100
PERITONITIS 
 
14
131
SBP
SBP PRESENT
SBP ABSENT
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TABLE: 10 COMPLICATIONS ASSOCIATED WITH DCLD  
(ON ADMISSION) 
Count % 
HbsAg Positive 
3 2.1% 
Negative 
142 97.9% 
Ascites Yes 122 84.1% 
No 23 15.9% 
PHT Yes 89 61.4% 
No 56 38.6% 
UGI Bleed Yes 30 20.7% 
No 115 79.3% 
Coagulopathy Yes 22 15.3% 
No 122 84.7% 
HRS Yes 16 11.0% 
No 129 89.0% 
SBP present 14 9.7% 
Absent 
131 90.3% 
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FIGURE 23 : COMPLICATIONS OF DCLD 
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TABLE : 11 DISTRIBUTIONS OF VARIABLES 
 
 
The mean serum sodium is 127.3 mEq/L, serum bilirubin 6.16 mg/dL, 
serum Albumin 2.62 mg/dL.  
 
 
 
 
 
 
 
Mean 
Standard 
Deviation 
Maximum Minimum 
Serum 
Sodium 
127.30 5.53 144.00 110.00 
Serum 
Bilirubin 
6.16 2.98 18.40 0.60 
Serum 
Albumin 
2.62 0.47 3.40 1.40 
INR 1.32 0.52 0.45 3.00 
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TABLE: 12 COMPLICATIONS IN RELATION TO SERUM SODIUM 
 
GROUP 
p value 
by Chi 
square 
test 
Na <= 125 mEq/L Na > 125 mEq/L 
Count % Count % 
Ascites 
Yes 45 100.0% 77 77.0% 
<0.001 
No 0 0.0% 23 23.0% 
PHT 
Yes 36 80.0% 53 53.0% 
0.002 
No 9 20.0% 47 47.0% 
UGI Bleed 
Yes 9 20.0% 21 21.0% 
0.891 
No 36 80.0% 79 79.0% 
Coagulopathy 
Yes 19 42.2% 3 3.0% 
<0.001 
No 26 57.8% 96 97.0% 
HRS 
Yes 11 24.4% 5 5.0% 
0.001 
No 34 75.6% 95 95.0% 
SBP 
High 6 13.3% 8 8.0% 
0.129 
Normal 39 86.7% 92 92.0% 
 
Of the 145 patients 45 patients has serum sodium <125 mEq/L.100 
patients has serum sodium >125 mEq/L and the complications were analyzed 
in relation to these two groups 
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TABLE: 13 COMPARISON OF ASCITES IN RELATION TO  
SERUM SODIUM GROUPS 
Of the Patients with serum sodium <125 mEq/L  45 out of 45 (100%) 
has ascites and 77 (77%) patients whose serum sodium >125 mEq/L has 
ascites. Its p value is < 0.001, which is significant 
 
ASCITES 
Na <125 mEq/L Na >125 mEq/L 
P value 
Count percent Count Percent 
Present 45 100% 77 77% 
 
 
< 0.001 
Absent 0 0 23 23% 
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Figure: 24 comparison of Ascites between serum sodium groups 
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TABLE: 14 COMPARISON OF PORTAL HYPERTENSION  
BETWEEN SERUM SODIUM GROUPS 
Of the patients with serum sodium < 125mEq/L group 36 out of  
45 patients (80%) has PHT. In serum sodium > 125 mEq/L group 53 out of 100 
(53%) patients has PHT.p value is 0.002 is significant.   
Portal HT 
Na <125 mEq/L Na >125 mEq/L 
P value 
Count Percent Count Percent 
Present 36 80% 53 53% 
 
0.002 
Absent 9 20% 47 47% 
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FIGURE : 25 COMPARISON OF PORTAL HYPERTENSION 
BETWEEN SERUM SODIUM GROUPS 
 
 
 
60 
 
 
TABLE: 15 COMPARISON OF UGI BLEED BETWEEN SERUM 
SODIUM GROUPS 
In serum sodium group <125mEq/L only 9 out of 45 patients (20%) has 
UGI bleed. In serum sodium >125 mEq/L 21out of 100 patients (21%) has UGI 
bleed. Its p value is 0.891 which is not significant. 
UGI BLEED 
Na <125 mEq/L Na >125 mEq/L 
P value 
Count percent Count Percent 
Present 9 20% 21 21% 
 
 
< 0.891 
Absent 36 80% 79 79% 
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FIGURE : 26 COMPARISON OF UGI BLEED BETWEEN  
SERUM SODIUM GROUPS 
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TABLE: 16 COMPARISON OF COAGULOPATHY BETWEEN SERUM 
SODIUM GROUPS 
In serum sodium < 125mEq/L group 19 out of 45(42.2%) has 
coagulopathy. In the serum sodium >125 mEq/L group 3 out of 100 (3%) has 
coagulopathy. p value is   < 0.001 
Coagulopathy 
Na <125 mEq/L Na >125 mEq/L 
P value 
Count percent Count Percent 
Present 19 42.2% 3 3% 
 
 
< 0.001 
Absent 26 57.8% 96 97% 
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FIGURE: 27 COMPARISON OF COAGULOPATHY IN  
RELATION TO SERUM SODIUM 
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TABLE: 17 COMPARISON OF HRS BETWEEN  
SERUM SODIUM GROUPS 
In Serum Sodium Group <125meq/L 11 out of 45(24.4%) has HRS. 
Whereas in serum sodium >125 Meq/L group only 5 out of 100 has HRS.P 
value is 0.001 which is significant.  
 
HRS 
Na <125 mEq/L Na >125 mEq/L 
P value 
Count percent Count Percent 
Present 11 24.4% 5 5% 
 
 
0.001 
Absent 34 75.6% 95 95% 
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FIGURE : 28 COMPARISON OF HRS BETWEEN  
SERUM SODIUM GROUPS 
 
 
 
 
 
66 
 
TABLE : 18 COMPARISON OF HEPATIC ENCEPHALOPATHY 
BETWEEN SERUM SODIUM GROUPS 
 
In serum sodium <125 mEq/L group 20 out of 45 (34.5%) has hepatic 
encephalopathy in different grades. In serum sodium group > 125mEq/L 8 out 
of 100 (8%) has hepatic encephalopathy. P value is < 0.001 is significant. 
 
Hepatic 
encephalopathy 
GROUP 
p value by 
Chi square 
test 
Na <= 125 mEq/L Na > 125 mEq/L 
Count % Count % 
Nil 25 55.6% 92 92.0% 
<0.001 
Grade 1 7 15.6% 7 7.0% 
Grade 2 4 8.9% 1 1.0% 
Grade 4 
9 20.0% 0 0.0% 
 
 
 
 
  
  
FIGURE : 29 COMPARISON OF HEPATIC ENCEPHALOPATHY 
BETWEEN SERUM SODIUM GROUPS
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TABLE: 19 DISTRIBUTIONS OF CHILD PUGH CLASS AT THE  
TIME OF ADMISSION 
 
Patients are assesed at time of admission and various parameters are 
studied. Out of 145 patients 2 (2%) patients were in child Pugh class A.28 
(19%) patients were child pugh class B.115 (79%) patients were in class 
C.Most of the patients were in Child class C 
CHILD PUGH 
CLASS 
NO OF PATIENTS PERCENTAGE 
A 2 2% 
B 28 19% 
C 115 79% 
 
 
 
 
 
 
 
 
 
 
 
  
FIGURE : 30 DISTRIBUTIONS OF CHILD PUGH CLASS AT THE 
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TIME OF ADMISSION 
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TABLE : 20 DISTRIBUTIONS OF VARIABLES IN RELATION TO 
SERUM SODIUM 
In serum sodium <125 mEq/L group serum bilirubin mean was 8.04,  
SD was 1.61 and, whereas in >125 mEq/L group mean was 5.32,SD was 3.07, 
p value was < 0.001 
In serum sodium <125 mEq/L group serum albumin mean was 2.21,  
SD was 0.44 and, whereas in >125 mEq/L group mean was 2.81,SD was 0.34, 
p value was < 0.001 
 
In serum sodium <125 mEq/L group INR mean was 1.67, SD was 
0.71and,whereas in >125 mEq/L group mean was 1.16,SD was 0.31, p value 
was  < 0.001 
 
 
 
GROUP N MEAN STD. DEVIATION 
p VALUE 
BY ‘t’ 
TEST 
Serum 
Bilirubin 
Na <= 125 mEq/L 45 8.04 1.61 <0.001 
Na > 125 mEq/L 100 5.32 3.07 
Serum 
Albumin 
Na <= 125 mEq/L 45 2.21 0.44 <0.001 
Na > 125 mEq/L 100 2.81 0.34 
INR Na <= 125 mEq/L 45 1.67 0.71 <0.001 
Na > 125 mEq/L 100 1.16 0.31 
 FIGURE : 31 MEAN OF SERUM 
INR WITH RESPECT TO SERUM SODIUM
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 FIGURE : 32 SD OF SERUM BILIRUBIN, ALBUMIN, INR WITH 
RESPECT TO SERUM SODIUM
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TABLE : 20 COMPARISON OF CHILD PUGH CLASS ON 
ADMISSION AND FOLLOW UP BETWEEN  
SERUM SODIUM GROUPS 
On admission out of 45 in serum sodium group <=125 mEq/L 45(100%) 
were in Child class C. On follow up with treatment 23(54.8%) were in Child 
class B and 19(45.2%) were in Child class C.p value was < 0.001.3 patients 
expired on follow up. 
On admission out of 100 in serum sodium group > 125 mEq/L 2 (2%) 
were in Child class A, 28 (28%) were in Child class B,70(70%) were in Child 
class C. On follow up with treatment 6 (6%) were in child class A, 88(88%) 
were in Child class B and 6 (6%) were in Child class C. 
 
CHILD PUGH 
CLASS 
GROUP 
p value by 
Chi square 
test 
Na <= 125 mEq/L Na > 125 mEq/L 
Count % Count % 
Admission A 0 0.0% 2 2.0% 
<0.001 B 0 0.0% 28 28.0% 
C 45 100.0% 70 70.0% 
Follow up A 0 0.0% 6 6.0% 
<0.001 B 23 54.8% 88 88.0% 
C 19 45.2% 6 6.0% 
 
  
74 
 
FIGURE: 33 COMPARISON OF CHILD PUGH CLASS ON 
ADMISSION AND FOLLOW UP WITH RESPECT TO  
SERUM SODIUM GROUPS 
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FIGURE : 34 COMPARISONS OF CHILD PUGH SCORE ON 
ADMISSION AND FOLLOWUP WITH SERUM SODIUM GROUPS 
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TABLE : 21 COMPARISON OF MORTALITY IN RELATION TO 
SERUM SODIUM GROUPS 
 
Out of 145,3 (6.7%) patients expired on follow up. All of them in the 
serum  sodium group <= 125 mEq/L group. 
 
SERUM 
SODIUM 
TOTAL 
PATIENTS 
NO OF 
DEATHS PERCENTAGE 
<= 125mEq/l 45 3 6.7% 
> 125mEq/l 100 NIL NIL 
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FIGURE : 35 COMPARISON OF MORTALITY IN RELATION TO 
SERUM SODIUM GROUPS 
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DISCUSSION 
In this study patients admitted in study centre with features of 
decompensated liver disease diagnosed based on liver function tests, imaging, 
viral markers and importantly clinical history are included in the study after 
excluding those positive for exclusion criteria.  
Following parameters are studied, serum sodium , serum bilirubin, 
serum albumin, INR, serum creatinine and complications like Ascites, portal 
HT, HRS, spontaneous bacterial peritonitis, coagulopathy, UGI bleed. The 
patients were analyzed based on their serum sodium levels to assess the 
significance and relation with complications. 
145 patients were studied, of them 142 were male and 3 were female. 
Most of the patients were in the age group between 40 to 70 years of 
age, it was around 120 patients. It indicates most of presentations of disease 
may occur in patients above 40 years. The mean age was 51.75 years with 
standard deviation of 9.7. 
Regarding the etiology of cirrhosis 142 (98%) patients were due to 
alcohol background, only 3 (2%) were due to infective pathology that due to 
Hepatitis B. 
In relation to complications ascites was associated with 142 (97.9%) 
patients and portal HT was seen in 89 (61.4%) patients.UGI bleed was 
associated with 30 (20.7%),coagulopathy 22 (15.3%), HRS 16 
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(11%),Spontaneous Bacterial peritonitis 14 (9.7%). Ascites and Portal HT was 
associated more commonly with DCLD. 
Further the patients were divided into groups, one with serum sodium 
<= 125mEq/L and > 125 mEq/L, assesed at admission and followed up to 
assess the significance of hyponatremia. For assessment Modified Child Pugh 
Score was used. 
Of the 145, 45 has serum sodium <= 125mEq/L and 100 patients with 
serum sodium > 125 mEq/L.  
All (100%) patients with serum sodium <= 125 mEq/L has ascites. But 
77% of patients with serum sodium >125 mEq/L has ascites. It has significant  
p value of <0.001.Hence ascites may be more common with severe 
hyponatremia in DCLD. 
About 80% of patients with serum sodium <= 125 mEq/L has PHT. 
Also 53% of patients with serum sodium > 125 mEq/L has PHT, with a P value 
of 0.002 which is significant. Hence patients in former group was most 
commonly associated with PHT. 
UGI bleed was associated with 20% of patients with serum sodium <= 
125 mEq/L and 21 % of serum sodium serum sodium >125 mEq/L. There was 
no significant association based on p value 0.891. 
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Coagulopathy was associated with 42.2% of patients with serum sodium 
<= 125 mEq/L and 3% with serum sodium > 125 mEq/L. There was significant 
association with p value of < 0.001. 
HRS was associated with 24.4% of patients with serum sodium <= 125 
mEq/L and 5% of patients with serum sodium >125 mEq/L, with p value of 
0.001. 
SBP was associated with 13.3% of patients with serum sodium <= 125 
mEq/L and 8% of patients with serum sodium > 125 mEq/L with p value of 
0.129. There is no significant relation with respect to serum sodium.  
Hepatic encephalopathy in patients with serum sodium <= 125 mEq/L 
were 15.6% in grade 1, 8.9% in grade 2, 20% in grade 4,55.6% has no 
encephalopathy. But in serum sodium >125 mEq/L it was 7% in grade 1, 1% in 
grade 2, no patient in grade 4.Also 92% has no encephalopathy compared with 
55.6 % in other group. 
Child Pugh score was applied and classified on basis of modified Child 
Pugh on admission and followup. 
In serum sodium <= 125 mEq/L 100% were in child class C on 
admission, on comparison in serum sodium >125 mEq/L patients 28% were 
child class B,70% were in child class C.with p value of < 0.001 with significant 
association. 
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In serum sodium <= 125 mEq/L on follow up 54.8% were in child class 
B, 45.2% in child class C. There was some improvement following treatment 
about 50% downgraded to class B. 
But in serum sodium > 125 mEq/L 6% were in child class A,88% in 
child class B,6% in class C. There is much improvement following treatment. 
Only 6% were in Child C. Its p value was <0.001.Eventhough serum sodium 
cannot be normalized improvement of sodium >125 mEq/L has influence on 
outcome. 
Also 3 patients expired on follow up all of them had serum sodium <= 
125 mEq/L. 
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CONCLUSION 
In DCLD hyponatremia is frequent association. This study was done to 
signify the importance of serum sodium and it’s use as prognostic factor in 
DCLD patients to predict impending complications. 
In patients with serum sodium <= 125 mEq/L were associated with more 
complications, more severity based on Child Pugh  class and mortality, 
compared with slightly decreased complications, severity and  less percentage 
in child class C and favorable improvement on follow up. 
Hence patients with severe hyponatremia will be associated with more 
complications and hence higher in Child class and associated with mortality. 
The degree of decrease in serum sodium can be used to predict the 
prognosis of patients with DCLD. 
Thus, Serum sodium can be used as prognostic factor in patients with 
Decompensated liver disease. 
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SUMMARY 
• In this study 145 patients were observed, of them 142 male, 3 were 
female. 
• Alcohol was most common etiology for DCLD in this study. 
• Most patients were associated with ascites, PHT. 
• Further they were grouped with serum sodium <= 125 mEq/L and serum 
sodium > 125 mEq/L and child Pugh score were used on admission and 
follow up. 
• Complications like ascites, PHT, coagulopathy, hepatic encephalopathy 
were more commonly  associated with serum sodium <= 125 mEq/L 
with p value of <0.05 compared to serum sodium >125 mEq/L 
• 100% of patients were in child class c in serum sodium <= 125 mEq/L 
with p value of < 0.001 on admission also on follow up 45.2% were in 
child class C 
• Conversely 70% in serum sodium > 125 mEq/L in child class on 
admission on follow up only 6% were in child class c. 
• Patient with serum sodium > 125 mEq/L has better prognosis compared 
to serum sodium <= 125 mEq/L 
• Mortality was associated with serum sodium <= 125 mEq/L. 
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RENAL FUNCTION TEST 
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SERUM CREATININE : 
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SGPT     : 
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SERUM PROTEIN  : 
SERUM ALBUMIN  : 
 
COAGULATION PROFILE 
PROTHROMBIN TIME  : 
INR     : 
USG ABDOMEN   : 
PORTAL VEIN DOPPLER : 
 
COMPLICATIONS: 
 ASCITES               : PRESENT/ABSENT 
 PORTAL  
HYPERTENSION  : PRESENT/ABSENT 
 UGI BLEED   : PRESENT/ABSENT 
 COAGULPATHY  : PRESENT/ABSENT 
 SBP     :  PRESENT/ABSENT 
 HEPATIC  
ENCEPHALOPATHY : PRESENT/ABSENT 
 HEPATORENAL 
SYNDROME  : PRESENT/ABSENT 
 
CHILD PUGH SCORE 
SERUM TOTAL BILIRUBIN  : 
SERUM ALBUMIN   : 
PROTHROMBIN TIME   : 
ASCITES     : 
HEPATIC ENCEPHALOPATHY  : 
TOTAL SCORE    : 
CHILD PUGH CLASS   : 
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INFORMATION SHEET 
We are conducting a study on “SERUM SODIUM AS A 
PROGNOSTIC FACTOR IN DECOMPENSATED LIVER 
DISEASE” among patients attending Rajiv Gandhi Government General 
Hospital, Chennai and for that your specimen may be valuable to us. The 
purpose of this study is to ascertain the importance of serum sodium and 
its prognostic value in patients with decompensated liver disease. 
We are selecting certain cases and if you are found eligible, we 
may perform extra tests and special studies which in any way do not 
affect your final report or management. 
The privacy of the patients in the research will be maintained 
throughout the study. In the event of any publication or presentation 
resulting from the research, no personally identifiable information will be 
shared. 
Taking part in this study is voluntary. You are free to decide 
whether to participate in this study or to withdraw at any time; your 
decision will not result in any loss of benefits to which you are otherwise 
entitled. 
The results of the special study may be intimated to you at the end 
of the study period or during the study if anything is found abnormal 
which may aid in the management or treatment. 
Signature of Investigator                           Signature of Participant 
Date : 
Place : 
PATIENT CONSENT FORM 
Study Detail : SERUM SODIUM AS A PROGNOSTIC 
FACTOR IN DECOMPENSATED LIVER 
DISEASE 
Study Centre : Rajiv Gandhi Government General Hospital, 
Chennai. 
Patient’s Name :  
Patient’s Age :  
Identification 
Number 
:  
Patient may check (☑) these boxes 
I confirm that I have understood the purpose of procedure for the above 
study. I have the opportunity to ask question and all my questions and 
doubts have been answered to my complete satisfaction.  
I understand that my participation in the study is voluntary and that I am 
free to withdraw at any time without giving reason, without my legal 
rights being affected.  
I understand that sponsor of the clinical study, others working on the 
sponsor’s behalf, the ethical committee and the regulatory authorities 
will not need my permission to look at my health records, both in 
respect of current study and any further research that may be conducted 
 
in relation to it, even if I withdraw from the study I agree to this access. 
However, I understand that my identity will not be revealed in any 
information released to third parties or published, unless as required 
under the law. I agree not to restrict the use of any data or results that 
arise from this study. 
I agree to take part in the above study and to comply with the instructions 
given during the study and faithfully cooperate with the study team and 
to immediately inform the study staff if I suffer from any deterioration 
in my health or well being or any unexpected or unusual symptoms.  
I hereby consent to participate in this study.  
I hereby give permission to undergo complete clinical examination and 
diagnostic tests including hematological, biochemical, radiological tests.  
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1 Chandrasekar 65 Male 124 5.8 2.8 Present Present Nil Nil 1 Nil Nil Nil 128 3.2 2.9 mild Present Nil Nil 1 Nil Nil Nil 9 B
2 Rajendran 70 Male 121 7.4 2.1 Present Present N Nil 0.9 Present Grade 1 Nil 126 3 2.6 Present Present N Nil 0.9 absent Nil Nil 9 B
3 Raja 40 Male 133 3.2 3.4 Present Nil Nil Nil 0.87 Nil Nil Nil 131 2 3.3 mild Nil Nil Nil 0.87 Nil Nil Nil 8 B
4 Thulasingam 40 Male 128 5.3 2.9 Present Present Present Nil 1.3 Nil Nil Nil 129 3.5 3 mild Present nil Nil 1.3 Nil Nil Nil 9 B
5 Raja 48 Male + 118 6.3 1.9 Present Nil Nil Nil 1.1 Nil Nil Nil 132 4.5 2.4 mild Nil Nil Nil 1.1 Nil Nil Nil 10 C
6 Manokaran 43 Male 116 9.4 2.2 Present Present Nil Nil 1.4 Nil Nil Nil 128 3.8 2.6 mild Present Nil Nil 1.4 Nil Nil Nil 10 C
7 Chakravarthy 75 Male 139 4.2 2.9 Present Present Nil Nil 1.2 Nil Nil Nil 135 2.8 2.8 mild Present Nil Nil 1.2 Nil Nil Nil 8 B
8 Velumani 45 Male 122 9.4 1.6 Present Present Nil Nil 0.98 Nil Nil Nil 128 2.9 2.4 mild Present Nil Nil 0.98 Nil Nil Nil 9 B
9 Chokkalingam 62 Male 124 5.7 2.6 Present Present Present Nil 0.8 Nil Nil Nil 127 4.5 2.7 mild Present nil Nil 0.8 Nil Nil Nil 10 C
10 Prabhakaran 56 Male 110 7.4 2.4 Present Present Present Nil 1.08 Present Grade 4 Nil 125 3.5 2.8 mild Present nil Nil 1.08 Nil grade 1 Nil 10 C
On follow up
parameters Complications
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+
parameters Complications
On Admission CHILD 
PUGH
11 Anand 45 Male 128 5.2 2.9 Present Nil Nil Nil 1.45 Nil Nil Nil 129 3.5 2.8 Nil Nil Nil Nil 1.45 Nil Nil Nil 8 B
12 Saroja 55 Female 124 7.2 2.8 Present Present Present Nil 1.38 Nil Nil Nil 129 2.5 2.6 mild Present ni Nil 1.38 Nil Nil Nil 9 B
13 Shanmugam 57 Male 119 11.6 1.6 Present Present Nil Present 2.5 Present Nil Nil 125 4.5 2.4 mild Present Nil ni 1.4 n Nil Nil 10 C
14 Dass 35 Male 125 7.4 2.4 Present Nil Nil Nil 1.5 Nil Nil Pres
ent 
127 2.1 2.8 mild Nil Nil Nil 1.5 Nil Nil Nil 8 B
15 Arulmozhivarman 45 Male 121 6.4 2.8 Present Present Nil Nil 1.34 Present Nil Nil 126 3.8 2.9 mild Present Nil Nil 1.34 nil Nil Nil 9 B
16 Karthi 44 Male 129 2.4 3.2 Nil Present Present Nil 1.26 Nil Nil Nil 127 2.6 3 Nil Present nil Nil 1.08 Nil Nil Nil 7 B
17 Suresh 40 Male 132 3.5 3.1 Nil Nil Nil Nil 1.34 Nil Nil Nil 130 2.2 3 Nil Nil Nil Nil 1.34 Nil Nil Nil 7 B
18 Venkatesan 48 Male 112 9.5 1.8 Present Present Nil Present 1.9 Present Grade 4 Nil 124 4.2 2.4 mild Present Nil nil 1.12 nil grade 1 Nil 11 C
19 Ganesan 67 Male 128 5.4 2.8 Nil Present Nil Nil 1.42 Present Nil Nil 127 2.8 2.6 Nil Present Nil Nil 0.96 nil Nil Nil 8 B
20 Yesu 59 Male 125 8.4 2.6 Present Nil Present Nil 1.32 Present Nil Nil 129 3.2 2.9 mild Nil nil Nil 1.24 nil Nil Nil 9 B
21 Subramani 52 Male 134 3.2 3.4 Nil Nil Present Nil 1.46 Nil Nil Nil 134 3.2 3.4 Nil Nil nil Nil 1.46 Nil Nil Nil 8 B
22 Moses 49 Male 120 10.5 2.1 Present Present Present Nil 1.17 Nil Grade 2 Nil 126 3.5 2.8 mild Present nil Nil 0.96 Nil grade 1 Nil 10 C
23 Arumuham 38 Male 126 5.4 2.6 Nil Present Present Nil 1.34 Nil Nil Pres
ent 
128 2.1 2.7 Nil Present nil Nil 0.87 Nil Nil nil 8 B
24 Gopi 45 Male 132 2.4 3.2 Nil Nil Nil Nil 1.24 Nil Nil Nil 130 1.6 2.4 Nil Nil Nil Nil 1.24 Nil Nil Nil 7 B
25 Purushothaman 57 Male 114 9.6 1.8 Present Present Nil Present 2.4 Present Grade 4 Nil 127 3.2 2.4 mild Present Nil nil 0.98 nil Nil Nil 10 C
26 Ravi 53 Male 126 5.4 2.8 Present Present Nil Nil 1.4 Nil Nil Nil 130 2 2.8 mild Present Nil Nil 1.24 Nil Nil Nil 8 B
27 Solai 66 Male 127 6.4 2.6 Present Present Nil Nil 1.22 Nil Grade 1 Pres
ent 
129 3.2 2.8 Nil Present Nil Nil 0.95 Nil Nil Nil 8 B
28 x 47 Male 118 10.4 1.6 Present Present Present Present 2.2 Nil grade 4 Nil expired
29 Sathasivam 65 Male 130 3.2 3.2 Nil Nil Nil Nil 1.24 Nil Nil Nil 131 1.8 3.4 Nil Nil Nil Nil 0.84 Nil Nil Nil 6 A
30 Murugan 39 Male 128 5.2 2.8 Nil Present Present Nil 1.36 Nil Nil Nil 130 2 2.9 Nil Present nil Nil 1.2 Nil Nil Nil 7 B
31 Vasanth 40 Male 131 3.2 2.9 Nil Nil Nil Nil 1.28 Nil Nil Nil 130 0.8 3 Nil Nil Nil Nil 1.1 Nil Nil Nil 6 A
32 Arul 52 Male 125 6.8 3 Present Nil Nil Nil 1 Present Nil Nil 128 3.5 3.2 mild Nil Nil Nil 0.53 nil Nil Nil 9 B
33 Sathiyam 46 Male 128 7.8 2.6 Present Nil Nil Nil 1.42 Nil Nil Pres
ent 
126 3.5 2.8 mild Nil Nil Nil 0.98 Nil Nil Nil 9 B
34 Kumar 55 Male 129 4.2 2.8 Present Present Nil Nil 1.36 Present Nil Nil 128 2.5 2.9 mild Present Nil Nil 0.56 nil Nil Nil 8 B
35 Vetri 40 Male 130 2.4 3.2 Nil Present Nil Nil 1.34 Nil Nil Nil 131 0.7 3.1 Nil Present Nil Nil 1 Nil Nil Nil 6 A
36 Velu 44 Male 124 9.6 2.2 Present Present Nil Nil 1.38 Nil Grade 1 Nil 128 3.5 2.6 mild Present Nil Nil 0.62 Nil Nil Nil 10 C
37 Palanisamy 53 Male 127 6.4 2.6 Present Nil Nil Nil 1.3 Present Grade 1 Nil 125 2 2.8 mild Nil Nil Nil 0.85 nil Nil Nil 8 B
38 Muthu 68 Male 120 8.4 1.8 Present Present Nil Present 3 Nil Grade 4 Nil 125 4 2.4 mild Present Nil Presen
t 
1.8 Nil grade 1 Nil 12 C
39 Sathish 41 Male 126 2.5 2.5 Nil Nil Nil Nil 1.32 Nil Nil Nil 124 1.8 2.6 Nil Nil Nil Nil 1.2 Nil Nil Nil 7 B
40 Radhakrishnan 56 Male 128 4.6 2.9 Nil Present Present Nil 1.44 Nil Nil Nil 130 2 3 Nil Present nil Nil 0.56 Nil Nil Nil 7 B
41 Thangam 54 Female 125 6.8 2.4 Present Nil Nil Present 2.1 Nil Nil Nil 127 3.5 2.8 mild Nil Nil nil 1.4 Nil Nil Nil 9 B
42 Velayutham 65 Male 129 4.2 2.9 Present Nil Nil Nil 1.45 Nil Nil Nil 128 2.2 2.6 mild Nil Nil Nil 1.2 Nil Nil Nil 9 B
43 Muthuvel 69 Male 123 8.6 2.4 Present Present Nil Nil 1.32 Present Nil Pres
ent 
127 2.5 2.6 mild Present Nil Nil 0.56 n Nil Nil 9 B
44 y 46 Male 117 7.4 2.1 Present Present Present Present 2.5 Nil Grade 2 Nil expired
45 Prasanna 35 Male 132 9.4 3.3 Nil Nil Nil Nil 1.4 Nil Nil Nil 130 2.5 3.2 Nil Nil Nil Nil 1.2 Nil Nil Nil 7 B
46 Saran 38 Male 130 4.2 3.2 Present Nil Nil Nil 1.26 Nil Nil Nil 129 2.2 3.1 mild Nil Nil Nil 0.95 Nil Nil Nil 8 B
47 Pichai 65 Male 125 8.5 2.6 Present Present Nil Nil 1.48 Nil Grade 1 Pres
ent 
128 3.2 2.4 mild Present Nil Nil 0.65 Nil Nil Nil 10 C
48 Farook 47 Male 127 5.6 2.9 Present Present Nil Nil 1.28 Nil Nil Nil 124 3.2 2.5 mild Present Nil Nil 0.54 Nil Nil Nil 10 C
49 Kuppusamy 55 Male 129 2.4 3.2 Present Nil Nil Nil 1.12 Nil Nil Pres
ent 
130 0.9 3 mild Nil Nil Nil 0.45 Nil Nil Nil 7 B
50 Appasamy 50 Male 125 7.6 2.8 Present Nil Nil Present 2.4 Nil Nil Pres 129 2.1 2.6 mild Nil Nil Presen 1.9 Nil Nil Nil 10 C
ent t 
51 Chokkalingam 56 Male 126 6.4 2.7 Present Present Present Nil 1.2 Nil Grade 1 Nil 128 3.5 2.6 mild Present nil Nil 0.69 Nil Nil Nil 10 C
52 Kaliamurthi 48 Male 128 4.2 2.9 Present Present Nil Nil 1.34 Nil Nil Nil 126 2.1 2.8 mild Present Nil Nil 1.02 Nil Nil Nil 8 B
53 Abbas 40 Male 125 7.4 2.4 Present Nil Nil Nil 1.36 Nil Nil Nil 126 3.5 2.6 mild Nil Nil Nil 0.84 Nil Nil Nil 10 C
54 Manickam 54 Male 127 4.6 2.6 Nil Present Present Nil 1.1 Nil Nil Nil 129 1.2 2.4 Nil Present nil Nil 0.84 Nil Nil Nil 7 B
55 z 44 Male 114 8.5 1.6 Present Present Nil Present 2.2 Present Grade 4 Nil expired
56 Krishnan 65 Male 123 6.5 2.3 Present Nil Nil Nil 1.42 Present Grade 1 Nil 126 2.8 2.6 mild Nil Nil Nil 0.62 nil Nil Nil 9 B
57 Vellaiyan 64 Male 126 5.8 2.1 Present Present Nil Nil 1.26 Nil Nil Pres
ent 
128 2.2 2.6 mild Present Nil Nil 0.45 Nil Nil Nil 9 B
58 Palani 51 Male 128 6.8 2.8 Nil Present Nil Nil 1.22 Nil Nil Nil 126 3.2 2.6 Nil Present Nil Nil 0.49 Nil Nil Nil 9 B
59 John 56 Male 112 7.9 1.4 Present Present Nil Present 2.6 Nil Grade 4 Nil 120 4.5 1.8 mild Present Nil nil 1.4 Nil grade 1 Nil 11 C
60 Sundaram 65 Male 126 5.8 2.6 Present Present Nil Nil 1.25 Present Nil Pres
ent 
128 2.5 2.8 mild Present Nil Nil 1.2 nil Nil Nil 8 B
61 Antony 47 Male 127 4.8 2.9 Present Present Nil Nil 1.28 Nil Nil Nil 126 2 2.8 mild Present Nil Nil 0.85 Nil Nil Nil 8 B
62 Saran 37 Male 132 5.3 3.2 Present Present Nil Nil 1.42 Nil Nil Nil 131 2.1 3 mild Present Nil Nil 1.1 Nil Nil Nil 8 B
63 Mohammed 58 Male 129 3.5 3.4 Present Present Present Nil 1.22 Nil Nil Nil 127 2 3.1 mild Present nil Nil 0.85 Nil Nil Nil 8 B
64 Vetrivel 62 Male 128 5.6 2.6 Present Present Nil Nil 1.1 Present Nil Nil 127 3 2.8 mild Present Nil Nil 0.75 nil Nil Nil 8 B
65 Kumerasan 46 Male 131 3.2 2.9 Present Nil Nil Nil 0.98 Nil Nil Nil 130 1.5 3.1 mild Nil Nil Nil 0.54 Nil Nil Nil 7 B
66 Suresh 39 Male 130 4.2 3.2 Present Present Nil Nil 0.86 Nil Nil Nil 131 2.2 3 mild Present Nil Nil 0.74 Nil Nil Nil 8 B
67 Ganga 45 Female 126 5.7 2.6 Present Present Nil Nil 0.86 Nil Grade 1 Nil 128 2.1 2.7 mild Present Nil Nil 0.45 Nil Nil Nil 9 B
68 Lokesh 47 Male 129 3.4 2.9 Present Present Nil Nil 0.78 Nil Nil Nil 127 2 2.8 mild Present Nil Nil 0.65 Nil Nil Nil 8 B
69 Mohan 56 Male 127 5.6 2.6 Present Present Nil Nil 1.34 Nil Grade 1 Nil 126 2.8 2.4 mild Present Nil Nil 1.2 Nil Nil Nil 9 B
70 Mani 65 Male 126 4.2 2.8 Present Present Nil Nil 1.24 Nil Grade 2 Nil 128 2 2.9 mild Present Nil Nil 0.85 Nil Nil Nil 8 B
71 Ravi 60 Male 131 12.2 2.3 Nil Present Present Nil 1.26 Nil Nil Nil 130 2.5 2.9 Nil Present nil Nil 0.95 Nil Nil Nil 7 B
72 Ramu 46 Male + 135 11.6 3.2 Present Present Nil Nil 1.12 Nil Nil Nil 132 4.5 3 mild Present Nil Nil 0.65 Nil Nil Nil 9 B
73 Saravanan 48 Male 127 18.4 2.6 Present Nil Nil Nil 1.32 Nil Nil Nil 129 5.5 2.4 mild Nil Nil Nil 0.98 Nil Nil Nil 10 C
74 Alayappan 60 Male 131 5 2.3 Present Nil Nil Nil 1.24 Nil Nil Nil 132 1.2 2.8 mild Nil Nil Nil 1.1 Nil Nil Nil 7 B
75 Murugan 45 Male 138 11.2 2.5 Present Present Present Nil 1.34 Nil Nil Nil 133 3.5 2.9 mild Present nil Nil 0.85 Nil Nil Nil 9 B
76 Arul vakku 53 Male + 130 0.9 3 Present Nil Nil Nil 1.25 Nil Nil Nil 131 0.8 3.1 mild Nil Nil Nil 0.65 Nil Nil Nil 7 B
77 Mani 60 Male 132 3.1 2.3 Present Nil Nil Nil 0.68 Nil Nil Nil 128 1.5 2.8 mild Nil Nil Nil 0.74 Nil Nil Nil 7 B
78 Gnanavel 26 Male 141 1.8 3.1 Nil Present Present Nil 1.58 Nil Nil Nil 135 0.9 3.2 Nil Present nil Nil 1.2 Nil Nil Nil 6 A
79 Kalaimani 46 Male 135 18.1 2.4 Present Present Nil Nil 1.46 Nil Nil Nil 132 5 2.6 mild Present Nil Nil 1.2 Nil Nil Nil 10 C
80 Rajesh 43 Male 134 5.3 2.9 Present Nil Nil Nil 1.36 Nil Nil Nil 130 2.2 2.6 mild Nil Nil Nil 1.24 Nil Nil Nil 9 B
81 Ramesh 43 Male 144 0.6 2.8 Present Nil Nil Nil 1.45 Nil Nil Nil 135 0.5 2.7 mild Nil Nil Nil 1 Nil Nil Nil 8 B
82 Palani 69 Male 144 0.7 2.8 Nil Present Present Nil 1.34 Nil Nil Nil 140 0.6 2.9 Nil Present nil Nil 0.96 Nil Nil Nil 6 A
83 Sriharikrishnan 39 Male 135 9.4 2.3 Present Nil Nil Nil 1.45 Nil Nil Nil 131 2.5 2.8 mild Nil Nil Nil 1.2 Nil Nil Nil 8 B
84 Arunachalam 37 Male 136 16.2 2 Present Present Present Present 1.76 Nil Nil Pres
ent 
134 3.2 2.4 mild Present nil nil 1.4 Nil Nil Nil 10 C
85 Rajendran 41 Male 134 6 2.7 Nil Present Present Nil 1.34 Nil Nil Nil 130 2 2.6 Nil Present nil Nil 1.1 Nil Nil Nil 8 B
86 Mani 50 Male 141 4.3 2.9 Nil Present Present Nil 1.25 Nil Nil Nil 134 2 3 Nil Present nil Nil 0.84 Nil Nil Nil 7 B
87 Sundar 54 Male 130 6.2 2.4 Present Nil Nil Nil 1.36 Nil Nil Nil 128 1.8 2.9 mild Nil Nil Nil 0.75 Nil Nil Nil 7 B
88 Ram 48 Male 128 10.6 2.1 Present Present Nil Nil 1.52 Nil Nil Nil 129 2.5 2.6 mild Present Nil Nil 1.2 Nil Nil Nil 9 B
89 Vaithiyanathan 55 Male 126 6.5 2.2 Present Nil Nil Present 2.2 Nil Nil Nil 128 2.8 2.6 mild Nil Nil Presen
t 
1.8 Nil Nil Nil 10 C
90 Basha 65 Male 130 7.6 2.5 Present Present Present Nil 1.24 Nil Nil Nil 131 2.5 2.8 mild Present nil Nil 0.95 Nil Nil Nil 8 B
91 James 58 Male 127 2.4 3 Nil Present Present Nil 1.36 Nil Nil Nil 128 0.9 2.9 Nil Present nil Nil 1.1 Nil Nil Nil 6 A
92 Soundar 49 Male 131 4.6 2.8 Present Nil Nil Nil 1.42 Nil Nil Nil 130 0.89 2.7 mild Nil Nil Nil 1.01 Nil Nil Nil 8 B
93 Thomas 66 Male 124 7.8 2.1 Present Present Nil Nil 1.34 Nil Nil Nil 127 2.5 2.6 mild Present Nil Nil 1.2 Nil Nil Nil 9 B
94 Raju 56 Male 120 12.4 1.8 Present Present Nil Present 2.3 Nil Nil Nil 125 2.5 2.4 mild Present Nil Nil 1.2 Nil Nil Nil 9 B
95 Santhosh 35 Male 131 2.3 2.9 Present Nil Nil Nil 1.38 Nil Nil Nil 132 1.2 3 mild Nil Nil Nil 0.72 Nil Nil Nil 7 B
96 Durai 62 Male 128 5.6 2.7 Nil Present Present Nil 1.44 Nil Nil Nil 129 2.1 2.8 Nil Present nil Nil 0.56 Nil Nil Nil 7 B
97 Vasanth 45 Male 132 2.5 2.4 Present Nil Nil Nil 1.42 Nil Nil Nil 130 1.4 2.8 mild Nil Nil Nil 1.21 Nil Nil Nil 7 B
98 Chelladurai 65 Male 122 10 1.8 Present Nil Nil Present 1.9 N Nil Nil 126 4.5 2.4 mild Nil Nil nil 1.5 nil Nil Nil 10 C
99 Sathya 43 Male 128 5.5 2.2 Present Nil Nil Nil 1.34 Nil Nil Nil 125 2.5 2.6 mild Nil Nil Nil 1.1 Nil Nil Nil 9 B
100 Venkatesan 52 Male 126 4.6 2 Nil Present Nil nil 1.35 Nil Grade 1 Nil 126 1.5 2.6 Nil Present Nil nil 1.35 Nil Nil Nil 7 B
101 Karthik 38 Male 132 4.5 3 Present Nil Nil Nil 0.87 Nil Nil Nil 130 2 3.1 mild Nil Nil Nil 0.95 Nil Nil Nil 8 B
102 Somu 49 Male 129 5.6 2.7 Present Present Nil Nil 0.68 Nil Nil Nil 127 1.9 2.6 mild Present Nil Nil 0.75 Nil Nil Nil 8 B
103 Venkatesh 56 Male 130 2.8 2.9 Present Nil Nil Nil 0.65 Nil Nil Nil 128 1.8 2.8 mild Nil Nil Nil 0.85 Nil Nil Nil 7 B
104 Soundarjan 65 Male 127 6.8 2.4 Present Present Nil Nil 0.78 Nil Grade 1 Nil 128 2.5 2.6 mild Present Nil Nil 0.85 Nil Nil Nil 9 B
105 Vetri 48 Male 131 4.5 3 Present Nil Nil Nil 0.56 Nil Nil Nil 129 2.1 3.1 mild Nil Nil Nil 0.84 Nil Nil Nil 8 B
106 Chandran 65 Male 123 9.5 1.8 Present Present Nil Present 2.4 Nil Grade 2 Pres
ent 
127 3.5 2.4 mild Present Nil Presen
t 
1.8 Nil Nil Nil 11 C
107 Duraisamy 68 Male 125 6.8 2.4 Present Present Nil Present 1.8 Nil Grade 1 Nil 127 2 2.6 mild Present Nil nil 1.3 Nil Nil Nil 9 B
108 Dinesh 36 Male 132 2.5 3.2 Present Nil Nil Nil 0.86 Nil Nil Nil 131 1.5 3.1 mild Nil Nil Nil 0.65 Nil Nil Nil 7 B
109 Madhan 42 Male 128 6.5 2.7 Present Present Nil Nil 0.56 Nil Nil Nil 127 2.5 2.9 mild Present Nil Nil 0.84 Nil Nil Nil 8 B
110 Singaram 68 Male 124 5.6 2.1 Present Present Nil Nil 0.68 Nil Nil Nil 128 1.8 2.6 mild Present Nil Nil 0.75 Nil Nil Nil 8 B
111 Jayasheelan 56 Male 127 7.6 2.4 Present Present Nil Present 1.8 Nil Nil Pres
ent 
128 2.5 2.6 mild Present Nil nil 1.2 Nil Nil nil 9 B
112 Raja 50 Male 131 3.6 3.2 Present Nil Nil Nil 0.45 Nil Nil Nil 132 2 3.1 mild Nil Nil Nil 0.68 Nil Nil Nil 8 B
113 Arumugam 70 Male 124 7.5 2.1 Present Present Nil Nil 0.56 Nil Nil Nil 128 2.5 2.6 mild Present Nil Nil 0.8 Nil Nil Nil 9 B
114 Santhosh 40 Male 129 4.3 2.9 Present Present Present Nil 0.67 Nil Nil Nil 127 2.4 3 mild Present n Nil 0.74 Nil Nil Nil 8 B
115 Varun 37 Male 130 3.7 3.2 Present Nil Nil Nil 0.98 Nil Nil Nil 131 2.1 3 mild Nil Nil Nil 0.68 Nil Nil Nil 8 B
116 Dhayalan 59 Male 122 8.9 1.8 Present Present Nil Present 2.4 Nil Grade 2 Pres
ent 
126 3.5 2.4 mild Present Nil nil 1.2 Nil Nil Nil 10 C
117 Ramesh 45 Male 128 4.5 2.9 Present Nil Nil Nil 0.78 Nil Nil Nil 127 0.9 2.8 mild Nil Nil Nil 0.5 Nil Nil Nil 7 B
118 Vasu 40 Male 126 5.5 2.8 Present Present Nil Nil 0.98 Nil Nil Nil 128 2.4 2.6 mild Present Nil Nil 0.67 Nil Nil Nil 9 B
119 Saravanan 45 Male 133 2.5 3.3 Present Nil Nil Nil 0.65 Nil Nil Nil 130 1.4 3.1 mild Nil Nil Nil 0.75 Nil Nil Nil 7 B
120 Venkataraman 65 Male 126 6.8 2.4 Present Present Nil Nil 0.68 Nil Nil Nil 129 2.9 2.8 mild Present Nil Nil 0.54 Nil Nil Nil 8 B
121 Antony 56 Male 121 8.5 1.6 Present Present Nil Present 2.8 Nil Grade 4 Nil 124 3.5 2.2 mild Present Nil nil 1.5 Nil grade 2 Nil 11 C
122 Jaffer 45 Male 131 3.4 3.2 Present Nil Nil Nil 0.87 Nil Nil Nil 130 2.1 3 mild Nil Nil Nil 0.8 Nil Nil Nil 8 B
123 Govindan 54 Male 128 5.5 3.1 Present Nil Nil Nil 0.98 Nil Nil Nil 129 2.5 3 mild Nil Nil Nil 0.62 Nil Nil Nil 8 B
124 Kasi 58 Male 127 6.5 2.8 Present Present Nil Nil 0.89 Nil Nil Nil 126 2.8 3 mild Present Nil Nil 0.64 Nil Nil Nil 8 B
125 Raghu 55 Male 125 9.6 2.5 Present Present Present Nil 0.54 Nil Nil Nil 128 2.6 2.8 mild Present nil Nil 0.84 Nil Nil Nil 8 B
126 Subramani 60 Male 124 6.8 2.9 Present Present Nil Nil 0.87 Nil Grade 1 Nil 126 3 3 mild Present Nil Nil 1 Nil Nil Nil 8 B
127 Velumani 57 Male 128 4.7 3.1 Present Nil Nil Nil 0.78 Nil Nil Nil 126 2 3 mild Nil Nil Nil 0.5 Nil Nil Nil 8 B
128 Anbu 53 Male 129 6.2 2.7 Present Present Present Nil 0.56 Nil Nil Nil 131 2 2.9 mild Present nil Nil 0.65 Nil Nil Nil 8 B
129 Prabhakaran 65 Male 123 8.5 2.5 Present Present Nil Present 3 Nil Nil Nil 127 1.9 2.8 mild Present Nil nil 1.5 Nil Nil Nil 7 B
130 Rajendran 54 Male 130 4.2 3.4 Present Nil Nil Nil 0.78 Nil Nil Nil 128 2.2 3.2 mild Nil Nil Nil 0.78 Nil Nil Nil 8 B
131 Velayutham 56 Male 126 5.6 2.4 Present Present Nil Nil 0.86 Nil Nil Nil 129 2.5 2.8 mild Present Nil Nil 1 Nil Nil Nil 8 B
132 Siva 45 Male 127 9.6 2.9 Present Nil Nil Nil 1.01 Nil Nil Nil 127 3.2 2.8 mild Nil Nil Nil 1.24 Nil Nil Nil 9 B
133 Ganesh 38 Male 131 4.6 3.2 Present Nil Nil Nil 0.95 Nil Nil Nil 130 2.2 3.1 mild Nil Nil Nil 0.84 Nil Nil Nil 8 B
134 Fazil 45 Male 129 3.5 3.1 Present Present Nil Nil 0.78 Nil Nil Nil 131 1.4 3.2 mild Present Nil Nil 0.82 Nil Nil Nil 7 B
135 Babu 53 Male 124 7.2 2.4 Present Present Nil Present 2.5 Nil Nil Nil 128 3.2 2.8 mild Present Nil nil 1.45 Nil Nil Nil 9 B
136 Sarath 35 Male 132 2.4 3.4 Present Nil Nil Nil 0.87 Nil Nil Nil 131 1.4 3.2 mild Nil Nil Nil 0.82 Nil Nil Nil 7 B
137 Velu 54 Male 126 5.6 2.5 Present Present Nil Nil 0.92 Nil Nil Nil 129 2.5 2.6 mild Present Nil Nil 0.75 Nil Nil Nil 9 B
138 Ramu 48 Male 128 5.3 3.2 Present Nil Nil Nil 0.85 Nil Nil Nil 126 2.8 3.1 mild Nil Nil Nil 0.81 Nil Nil Nil 8 B
139 Ananth 52 Male 127 4.8 2.7 Present Nil Nil Nil 1.2 Nil Nil Nil 129 2.3 2.8 mild Nil Nil Nil 0.98 Nil Nil Nil 8 B
140 Mohan 56 Male 125 5.6 2.9 Present Present Nil Nil 1.04 Nil Grade 1 Nil 128 1.8 2.8 mild Present Nil Nil 1.1 Nil Nil Nil 7 B
141 Venkat 50 Male 129 4.5 2.5 Present Nil Nil Nil 1.3 Nil Nil Nil 127 1.2 2.5 2.6 Nil Nil Nil 0.45 Nil Nil Nil 7 B
142 Thiru 46 Male 131 4.3 3.2 Present Nil Nil Nil 0.85 Nil Nil Nil 133 1 3.2 mild Nil Nil Nil 0.75 Nil Nil Nil 7 B
143 Kumaran 56 Male 123 6.8 2.1 Present Present Present Nil 1.5 Nil Nil Nil 126 2.5 2.6 mild Present nil Nil 1.1 Nil Nil Nil 9 B
144 Murugesan 65 Male 119 8.4 1.6 Present Present Nil Present 2.8 Nil Grade 4 Nil 124 3.4 2.1 mild Present Nil nil 1.4 Nil grade 1 Nil 11 C
145 Narayanan 63 Male 125 5.3 2.8 Present Present Nil Nil 0.98 Nil Nil Nil 129 1.8 2.9 mild Present Nil Nil 0.82 Nil Nil Nil 7 B
